Bone Biologics (BBLG) Return on Invested Capital (2016 - 2017)
Bone Biologics has reported Return on Invested Capital over the past 2 years, most recently at 0.01% for Q4 2017.
- Quarterly Return on Invested Capital fell 7.0% to 0.01% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2017, down 7.0% year-over-year, with the annual reading at 0.0% for FY2017, 3.0% down from the prior year.
- Return on Invested Capital was 0.01% for Q4 2017 at Bone Biologics, up from 0.02% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.08% in Q4 2016 and troughed at 0.02% in Q2 2017.